A study to see if a digital app designed to support patients in self-managing their COPD and highlight when they need to have a medication review with their healthcare provider is safe and effective
This study looks at a new feature within a digital app for people with COPD (Chronic Obstructive Pulmonary Disease). COPD is a common lung condition causing breathlessness and cough. The feature, an 'algorithm', aims to check if users' inhaler treatments match current guidelines. If it spots a difference, it alerts the user to discuss it with their healthcare team. The goal is to see if this helps people get the right medication for their needs, improving their symptoms and lowering their risk of serious flare-ups that might lead to hospital stays. Participants will use one of two versions of the app for six months, tracking their symptoms and medication daily.
At a glance
What is this study about?
COPD (Chronic Obstructive Pulmonary Disease) is a widespread lung condition that makes breathing difficult, causing symptoms like breathlessness, coughing, and wheezing. While there's no cure, inhaled medicines can help manage it. Sometimes, however, the treatments people receive don't always fully match the best recommendations, or their technique for using inhalers might not be quite right. This can mean people still experience troublesome symptoms.
Researchers are testing a new smart feature, called an 'algorithm', within a digital app (like a phone app) named MMH-LAB1. This algorithm looks at information people put into the app, such as their symptoms and current inhaler use. It then compares this to official guidelines for treating COPD. If the app's smart feature notices that someone's treatment might not be fully in line with these guidelines, it will gently suggest they talk to their doctor or nurse about their medication. There are two versions of the app in this study: one with this new smart feature and one without it, allowing researchers to compare them fairly. Please remember, this app is only for research and cannot change your medication – that’s always a decision you make with your healthcare team.
The main goal of this study is to see if this smart app feature can successfully help people with COPD get the most suitable treatment for them. If it works, it could lead to better control of symptoms, improve daily life, and potentially reduce flare-ups that sometimes land people in hospital. The study runs for six months, and the results will help us understand better ways to support people living with COPD.
Key takeaways
- A study for active users of the 'myCOPD' app.
- Tests a new app feature designed to help manage COPD medication.
- Aims to improve symptoms and reduce serious flare-ups.
- Involves using a test app daily for 6 months.
- The app suggests talking to your doctor about medication, it doesn't change it.
- Participation could help improve COPD care for others.
Who may be eligible?
To join this study, you need to be an adult over 18 years old. You must already have a diagnosis of COPD from your doctor and be a registered, active user of the 'myCOPD' app.
You also need to have filled out certain questionnaires within the 'myCOPD' app in the last year, specifically a 'CAT' questionnaire (which helps measure your COPD's impact on your life) and at least one form about any flare-ups you've had. This helps the researchers understand your condition better. Importantly, you also need to have previously agreed within the 'myCOPD' app to be contacted for research studies.
One important point is that you must be able to read and write in English to understand the study materials. If you meet these points, you might be suitable for the study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a doctor-diagnosed COPD?
- Are you an active user of the 'myCOPD' app?
- Have you agreed to be contacted for research within the 'myCOPD' app?
- Can you read and write in English?
What does participation involve?
If you decide to take part in this study, you will need to download an extra app called 'MMH-LAB1'. For six months, you will use this new app daily to record your COPD symptoms and the medications you are taking. Once a month, you'll also complete a questionnaire about your general health and how you're using healthcare services. At the very end of the six months, there will be one final 'Feedback' questionnaire to complete.
If you are randomly chosen to be in the group that receives the new smart app feature (called the 'intervention arm'), the app might tell you if your symptoms and medication details suggest your treatment isn't fully following the guidelines. If this happens, it will suggest you should talk to your GP or healthcare provider about reviewing your medication. This group will also have access to a 'Patient Advocate' who can help support you when you speak with your healthcare team.
Potential risks and benefits
Locations (1)
- Southampton General HospitalApproximateSouthampton, England
Common questions
What is COPD?
COPD is a common, long-term lung condition that makes it hard to breathe. Symptoms include breathlessness, coughing, and wheezing.
What is this study trying to find out?
It's trying to see if a new app feature can help people with COPD get the most suitable medication for their condition, improving their symptoms and reducing flare-ups.
How long will I need to take part?
If you join the study, you'll be involved for six months.
Can the app change my medication?
No, the app cannot change your medication. It can only suggest you speak to your doctor or nurse about your treatment.
Who is paying for this study?
The study is funded by the National Institute for Health and Care Research (NIHR).
How to find out more
Tom Wilkinson
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.